Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Clinical Development
Eli Lilly Focus on Phase III Trial for Alzheimer’s Treatment Following FDA Fast Lane Setback
The FDA ‘specifically requested’ data from at least 100 patients who received a minimum 12 months’ treatment of Lilly’s drug donanemab before the approval process could progress further.
Clinical Diagnostics
Long-Read Sequencing Named 'Method of the Year 2022'
Powering a more complete reading of genomic information, Nature hails long-read sequencing as the omics-based method of the year.
Clinical Development
FDA Approves Merck-Developed KEYTRUDA for Non-Small Cell Lung Cancer Therapy
KEYTRUDA demonstrated a clinically meaningful improvement in disease-free survival in patients following surgical resection and platinum-based chemotherapy.
Spatial Analysis
The Future of Spatial Technology, Analysis, and Imaging
This Insight Article looks at the short and long-term predictions for spatial technological regulation, standardisation, and collaboration for the omics field.
Biomarker Discovery & Development
Bioassay Optimisation: How the Pandemic Reshaped International Standards for New Therapeutics
The global race to develop, trial, and distribute a vaccine for Covid-19 may have permanently accelerated the development of future therapeutics, including treatments for cancer.
Clinical Diagnostics
FDA Clears Genomic Profiling Test for Solid Tumours
Regulatory approval for comprehensive genomic profiling test signifies “significant advancement in personalised cancer care.”
Genome Editing
FDA and NIH Sign Interagency Collaboration Agreement to Advance Proteogenomics Research
A memorandum of understanding has been reached between the U.S. Food and Drug Administration (FDA) and the National Cancer Institute (NCI) to provide a framework for solving complex problems in molecular characterisation and classification of tumours.
Clinical Development
FDA Commits to Increasing Diversity in Clinical Trials
The move follows steps announced by the EMA and the MHRA to ensure clinical trials are more reflective of patient populations.
Clinical Development
Predicting Parkinson’s Disease with Machine Learning
Understanding machine learning’s role in providing a biomarker for the neurological condition.
Diagnostic Development
Study Reveals Altered Spontaneous Brain Activity in People with Down Syndrome
A new study has revealed that using functional magnetic resonance techniques shows the differences in the spontaneous activity of the brain in people with Down syndrome compared to the general population.
Diagnostic Development
The Ethical Issues of Pre-Emptive Dementia Diagnosis
If you were at risk of developing Alzheimer’s disease, would you want to know?
Diagnostic Development
Low-Cost Method for Cancer Testing
The Heatrich-BS assay is a novel low-cost sequencing method for low-cost cancer testing.